ArticleInternational journal of medical sciences2025

Data Mining of the FDA Adverse Event Reporting System and Animal Experiments for Assessment of Rhabdomyolysis Risk Associated with Lipid-lowering Drugs.

Shinji Kobuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.